- Home
- UBXG vs MBRX Comparison
UBXG vs MBRX Comparison
Compare UBXG & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBXG
- MBRX
- Stock Information
- Founded
- UBXG 2018
- MBRX 2015
- Country
- UBXG China
- MBRX United States
- Employees
- UBXG N/A
- MBRX N/A
- Industry
- UBXG
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- UBXG
- MBRX Health Care
- Exchange
- UBXG Nasdaq
- MBRX Nasdaq
- Market Cap
- UBXG N/A
- MBRX 12.9M
- IPO Year
- UBXG 2024
- MBRX 2016
- Fundamental
- Price
- UBXG $2.82
- MBRX $0.30
- Analyst Decision
- UBXG
- MBRX Strong Buy
- Analyst Count
- UBXG 0
- MBRX 3
- Target Price
- UBXG N/A
- MBRX $5.33
- AVG Volume (30 Days)
- UBXG 6.9K
- MBRX 5.4M
- Earning Date
- UBXG 01-01-0001
- MBRX 08-13-2025
- Dividend Yield
- UBXG N/A
- MBRX N/A
- EPS Growth
- UBXG N/A
- MBRX N/A
- EPS
- UBXG N/A
- MBRX N/A
- Revenue
- UBXG $39,603,353.00
- MBRX N/A
- Revenue This Year
- UBXG N/A
- MBRX N/A
- Revenue Next Year
- UBXG N/A
- MBRX N/A
- P/E Ratio
- UBXG N/A
- MBRX N/A
- Revenue Growth
- UBXG N/A
- MBRX N/A
- 52 Week Low
- UBXG $2.36
- MBRX $0.25
- 52 Week High
- UBXG $567.04
- MBRX $4.71
- Technical
- Relative Strength Index (RSI)
- UBXG N/A
- MBRX 23.96
- Support Level
- UBXG N/A
- MBRX $0.25
- Resistance Level
- UBXG N/A
- MBRX $0.42
- Average True Range (ATR)
- UBXG 0.00
- MBRX 0.05
- MACD
- UBXG 0.00
- MBRX -0.02
- Stochastic Oscillator
- UBXG 0.00
- MBRX 10.90
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.